상세 보기
Retreatment of Chronic Hepatitis C Failed to Daclatasvir Plus Asunaprevir by Other Direct-acting Antivirals
Daclatasvir와 Asunapreiver 요법에 실패한 만성 C형간염의 다른 직접작용 항바이러스제 재치료
- Lee, Dong Hoon;
- Ryu, Soo Hyung;
- Myung, Hee Jun;
- Shin, Yun Jae;
- Lee, Si Hyeong;
- ... Park, Tae Young;
- 외 1명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0초록
The pegylated interferon plus ribavirin combination therapy has been used as the primary treatment for chronic hepatitis C (CHC) but fails to produce a sustained viral response (SVR) in many patients. In recent years, the treatment of CHC has been rapidly changing because of the introduction of direct-acting antivirals (DAAs), which have a high cure rate. However, retreatment of patients after failure of the first DAA therapy is difficult. We report two rare cases of CHC that showed acquired SVR with other DAA combinations after failure to daclatasvir and asunaprevir.
키워드
Hepatitis C; chronic; Antiviral agents; Daclatasvir; Asunaprevir; GENOTYPE 1; HCV; ABT-450/R-OMBITASVIR; RIBAVIRIN; DASABUVIR; PIBRENTASVIR; PHASE-3; ADULTS
- 제목
- Retreatment of Chronic Hepatitis C Failed to Daclatasvir Plus Asunaprevir by Other Direct-acting Antivirals
- 제목 (타언어)
- Daclatasvir와 Asunapreiver 요법에 실패한 만성 C형간염의 다른 직접작용 항바이러스제 재치료
- 저자
- Lee, Dong Hoon; Ryu, Soo Hyung; Myung, Hee Jun; Shin, Yun Jae; Lee, Si Hyeong; Park, Tae Young; Moon, Jeong Seop
- 발행일
- 2021-02
- 유형
- Article
- 저널명
- 대한소화기학회지
- 권
- 77
- 호
- 2
- 페이지
- 88 ~ 91
- 언어
- ENG
- 출판사
- Korean Soc Gastroenterology
- 발행국가
- 대한민국
- 분량
- 4 페이지
- ISSN
- E 2233-6869
P 1598-9992